Content
The toxins from alcohol damage the heart muscles, much like what it does with other organs. If the heart muscles become thinner and weaker, the heart is unable to pump out blood efficiently. As a result, it expands to hold extra blood, further causing the muscles to become fragile.
LIMITATIONS OF ACM STUDIES
Symptoms of ACM include shortness of breath, swollen ankles and legs, fatigue, and chest pain. Alcoholic cardiomyopathy is a form of dilated cardiomyopathy, where the heart’s chambers enlarge and weaken due to alcohol’s toxic effects on the heart muscle. Over time, the heart struggles to pump blood efficiently, leading to symptoms like shortness of breath, fatigue, and leg swelling. If untreated, it can progress to heart failure, a life-threatening condition requiring immediate medical attention. There is reduced cardiac function and widening of the left ventricle2 (part of the heart responsible for pumping oxygenated blood out of the heart to the rest of the body).
- Once assigned to a DRG, the hospital receives a set payment for the patient’s care, regardless of the actual services provided.
- While it can develop gradually and remain unnoticed for years, early identification and lifestyle changes can make a significant difference.
- Results from serum chemistry evaluations have not been shown to be useful for distinguishing patients with AC from those with other forms of DC.
- If you or someone you know exhibits any of the above symptoms and has a history of chronic alcohol consumption, it is crucial to seek medical attention immediately.
- These symptoms often occur in people who have a history of heavy alcohol use and do not have any other form of heart disease that might explain their symptoms, such as coronary artery disease.
What Are the Signs and Symptoms of Alcoholic Cardiomyopathy?
In 1819 the Irish physician Dr. Samuel Black, who had a special interest in angina pectoris described what is probably the first commentary pertinent to the ”French Paradox“ 91. This refers to the finding in the last century that moderate alcohol consumption could be the reason for the relatively low cardiovascular disease incidence in wine-drinking regions 92. Renaud and de Lorgeril 93 suggested that the inhibition of platelet reactivity by wine may be one explanation for protection from CAD in France.
- The end-systolic dimension was 3.3 cm and the end-diastolic dimension was 4.8 cm (Figure 2).
- Today, the evidence seems to suggest that the effect is a direct result of ethanol or its metabolites, which are formed during metabolism.
- A healthy diet incorporating fruits, vegetables, and whole grains can help improve the health of the heart.
- They found that there is about 14% loss of myocardial cells in the left ventricle of those rats.
How to Build Resilience in Addiction Recovery
Nutritional deficiencies are a critical, yet often overlooked, component in the development of alcoholic cardiomyopathy. Chronic alcohol use impairs the absorption of essential vitamins and minerals like thiamine, magnesium, selenium, and coenzyme Q10, all of which are vital for cardiac energy metabolism. Deficiencies in these nutrients can exacerbate mitochondrial dysfunction and oxidative stress in heart cells, hastening myocardial weakening and dilation. Even with moderate drinking, poor dietary habits can create a metabolic environment where alcoholic alcohol rehab damage accumulates faster. Addressing how does alcohol cause enlarged heart damage must include an evaluation of nutritional status to ensure comprehensive treatment.
Diagnosis and Tests
- In patients with alcohol-induced cardiomyopathy, the mainstay and goal of therapy is abstinence from alcohol.
- Early detection and management through lifestyle changes, including reduced alcohol consumption and proper medical care, can help mitigate these risks.
- Regional wall motion abnormalities are not uncommon, but they are usually less prominent than those observed in persons with ischemic heart disease.
- For patient education information, see the Mental Health Center, as well as Alcoholism, Alcohol Intoxication, Drug Dependence and Abuse, and Substance Abuse.
- This can be understood through clinical observations that highlight the mitochondria as the main target of oxidative damage.
Chronic liver disease, often caused by long-term alcohol abuse, is another risk factor. The liver plays a crucial role in metabolizing alcohol, and when damaged, the body is less able to process alcohol, leading to higher toxin levels that can affect the heart. Additionally, people with diabetes or obesity are at increased risk for heart problems, including alcoholic cardiomyopathy. According to the American Heart Association, alcoholic cardiomyopathy accounts for approximately 3-40% of all dilated cardiomyopathy cases in Western countries. It is more common in men, but women are also at risk, especially with long-term alcohol abuse.
In spite of the high prevalence of excessive alcohol consumption and of its consideration as one of the main causes of DCM, only a small number of studies have analysed the long-term natural history of ACM. Unfortunately, all the available reports were completed at a time when a majority of the current heart failure therapies were not available (Table 1). The diagnosis of ACM is usually one of exclusion in a patient with DCM with no identified cause and a long history of heavy alcohol abuse. According to most studies, the alcohol consumption required to establish a diagnosis of ACM is over 80 g per day during at least 5 years9-12.
Recognized as a significant health issue, particularly in individuals with chronic alcohol use, alcoholic cardiomyopathy has been a concern for decades. This article provides a clear and compassionate overview of alcoholic cardiomyopathy, covering its drug addiction treatment risk factors, symptoms, diagnostic tests, treatments, and lifestyle changes that can help manage the condition. By understanding this condition better, patients can take steps to improve their heart health and overall well-being.
Cardiac Effects of Alcohol
People with alcoholic cardiomyopathy often have a history of heavy, long-term drinking, usually between five and 15 years. Heavy drinking is alcohol consumption that exceeds the recommended daily limits. In many — if not most — cases, abstaining from alcohol can be enough to help people recover from alcohol-induced cardiomyopathy. In cases where people don’t recover fully by abstaining from alcohol, most people will still see noticeable improvements in their symptoms. In some cases, even just reducing alcohol intake to light or moderate levels can also lead to improvements. However, not drinking at all is still the best course of action whenever possible.
You’ll also have the opportunity to connect with our licensed Reframe coaches for more personalized guidance. If you think you might have an AUD, see your health care provider for an evaluation. Your provider can help make a treatment plan, prescribe medicines, and if needed, give you treatment referrals. Below are the ICD-9 codes that most closely match this ICD-10 code, based on the General Equivalence Mappings (GEMs). This ICD-10 to ICD-9 crosswalk tool is helpful for coders who need to reference legacy diagnosis codes for audits, historical claims, or approximate code comparisons. The following annotation back-references are applicable to this diagnosis code.
They try to control myocardial remodeling to avoid the progression of myocyte hypertrophy 39,148 or fibrosis 149 and ventricle dysfunction and dilatation, as well as to increase the degree of myocyte regeneration 150. They aim to control oxidative damage, myocyte hypertrophy, interstitial fibrosis, and persistent apoptosis. Pharmacological restoration of autophagic reflux by inhibition of soluble epoxide hydrolase has been described to ameliorate chronic ethanol-induced cardiac fibrosis in an in vivo swine model 151. In addition to these, stem-cell therapy tries to improve myocyte regeneration 112,152. However, these new strategies have not yet demonstrated their real effectiveness in clinical trials, require further evaluation, and are not approved for clinical use 147.